Rx-360 Expands into China
From ChinaDaily USA
The US-based Rx-360, a global pharmaceutical industry consortium of volunteers protecting patient safety and enhancing supply-chain security, plans to increase its activities in China, which has become a major supplier for the global drug industry.
The Washington-based nonprofit organization was established in 2009 to protect patient safety by sharing information and developing processes related to the integrity of the healthcare supply chain and the quality of materials within the supply chain.
"With globalization of distribution for both drug components and finished products, China has undoubtedly played an important role in the global pharmaceutical industry. The country has a large number of manufactures, supplying raw materials to the world," said Brian Johnson, chairman of Rx-360, who is also the senior director of supply chain security at the drug company Pfizer. "How to ensure the security of sourcing and supply chain and increase the awareness in the country becomes critical as with many problems that to date have yet to be resolved."
The group's work in China will parallel what it has been doing in the US and Europe for several years, such as raising awareness of issues that have an impact on the security and integrity of pharmaceutical products and sharing best practices through education It will also promote the efficient use of joint and shared audit programmes to continue to improve the transparency of supply channels.
The group has also developed a series of tools and published white papers to help the industry and regulators address key areas of supply-chain security such as cargo theft, illegal product diversion, economically motivated adulteration, monitoring of drug shortages.
"Our goal is to work with local industries and regulators to further our mission in China," said Johnson, adding that this is also a step for RX-360 to invite more participation by local suppliers throughout Asian countries.
Related News
-
News Eli Lilly gets ready to launch five new drugs in 2023
Eli Lilly, the American pharmaceutical company (IN, USA) are gearing up for a big year ahead, with hopes to launch five new drugs and capitalise on growing obesity and Alzheimer’s disease markets. -
News Amgen buys Horizon for $27.8 billion in bold step into the rare disease market
Amgen Inc buys pharmaceutical company Horizon Therapeutics in a multibillion-dollar deal, in hopes to capitalise on it's portfolio of drugs in the highly sort after rare disease market. -
News Pharma Supply Chain People Moves
The latest appointments and promotions across the pharmaceutical supply chain. -
News Merck to donate new Ebola vaccine to defend against outbreaks in Uganda
Pharmaceutical giant Merck has announced they will be speeding up the processing of a new vaccine against the latest strain of the Ebola virus, to be donated to a global non-profit organisation for distribution -
News CPHI Podcast Series: Driving innovation with pharmaceutical startups
The latest episode in the CPHI Podcast Series explores how startups are driving innovation by taking high-risk approaches and doing business with greater agility. -
News Greener and efficient processes: Quaternary Ammonium Salts
Quaternary Ammonium Salts play a crucial part in Organic Chemistry processes at many major industries. Discover why.
-
News Biosimilars save patients $11B annually, but barriers to adoption remain in US market
Biosimilars introduce competition into the biologics market, driving down prices and increasing patient access. -
News WHO recommends use of two monoclonal antibody treatments against Ebola
The health body recommended use of treatments by Regeneron and Ridgeback Bio
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance